)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
ABVC BioPharma (ABVC) investor relations material
ABVC BioPharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary3 Nov, 2025
Executive summary
Q3 2025 revenue was $1.28 million, up 230% year-over-year, driven by milestone licensing revenue from OncoX, ForSeeCon, and strong CNS, ophthalmology, and oncology segments; nine-month revenue reached $795,950, a 57% increase from the prior year.
Net loss for Q3 2025 was $1,287,523, a 164% increase from Q3 2024; nine-month net loss was $4,564,546, up 2% year-over-year.
Total assets as of September 30, 2025, were $21.18 million, up 181% from year-end 2024, reflecting significant investments in property and equipment.
The company completed full repayment of convertible notes with Lind Partners, reducing debt and potential dilution.
Maintains an asset-light model focused on licensing, partnerships, and collaborative development.
Financial highlights
Q3 2025 licensing revenue reached $1.28 million, up from $0.39 million in Q3 2024, a 230% increase year-over-year.
Gross profit for Q3 2025 was $795,950, compared to $388,980 in Q3 2024; nine-month gross profit was $795,950, up from $506,860.
Property and equipment (net) rose to $12.06 million from $0.51 million at year-end 2024, a 2,100% increase.
Cash and cash equivalents as of September 30, 2025, were $192,068; restricted cash was $661,843.
Working capital deficit as of September 30, 2025, was $2,434,951, improved from a $4,377,616 deficit at year-end 2024.
Outlook and guidance
Management is focused on converting strategic investments into sustainable revenue through licensing, milestone payments, and expansion of CDMO services.
Recent investments in Taiwan are expected to enhance future research and manufacturing capacity.
The company anticipates ongoing affiliate integration and project execution will contribute positively to cash flows over the next 12 months.
Plans include raising additional capital, controlling expenses, and reducing debt to address liquidity risks.
Focus remains on advancing key pipeline assets and exploring additional partnerships for long-term growth.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
ABVC BioPharma Inc. is a U.S.-based biotechnology company engaged in the research, development, and commercialization of pharmaceutical and medical device products. The company focuses on advancing drug candidates and therapies in areas such as oncology, central nervous system disorders, and ophthalmology. ABVC BioPharma leverages partnerships with research institutions and healthcare organizations to develop innovative treatment solutions. ABVC BioPharma Inc. is headquartered in Fremont, California, and its shares are listed on the Nasdaq Stock Market (NASDAQ).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage